Europe pharmacovigilance and drug safety software market was valued at $61.1 million in 2021 and will grow by 7.4% annually over 2021-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions.
Highlighted with 33 tables and 60 figures, this 119-page report "Europe Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Europe pharmacovigilance and drug safety software market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter"s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe pharmacovigilance and drug safety software market in every aspect of the classification from perspectives of Functionality, Clinical Phase, Method, Delivery Mode, Indication, End User, and Country.
Based on Functionality, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Adverse Event Reporting Software
- Drug Safety Audits Software
- Issue Tracking Software
- Fully Integrated Software
Based on Clinical Phase, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
By Method, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
By Delivery Mode, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- On-premise Delivery
- On-demand Delivery
By Indication, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Oncology
- Respiratory Disorders
- Cardiology
- Neurology
- Immunology
- Pain Management
- Other Indications
By End Users, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Business Process Outsourcing Firms (BPOs)
- Other End Users
Geographically, the following national/local markets are fully investigated:
- Germany
- UK
- France
- Spain
- Italy
- Netherlands
- Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Functionality, Delivery Mode and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Ab Cube
Accenture PLC
ArisEurope LLC
Cognizant Technology Solutions Corporation
Ennov Solutions Inc.
Extedo GmbH
Honeywell International Inc. (Sparta Systems Inc.)
IQVIA Inc.
Max Application
Oracle Corporation
Sarjen Systems Pvt. Ltd.
United BioSource LLC
Veeva Systems Inc.
Wipro Limited
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter"s Fiver Forces Analysis 39
3 Segmentation of Europe Market by Functionality 43
3.1 Market Overview by Functionality 43
3.2 Adverse Event Reporting Software 45
3.3 Drug Safety Audits Software 46
3.4 Issue Tracking Software 47
3.5 Fully Integrated Software 48
4 Segmentation of Europe Market by Clinical Phase 49
4.1 Market Overview by Clinical Phase 49
4.2 Pre-clinical 51
4.3 Phase I 52
4.4 Phase II 53
4.5 Phase III 54
4.6 Phase IV 55
5 Segmentation of Europe Market by Method 56
5.1 Market Overview by Method 56
5.2 Spontaneous Reporting 58
5.3 Intensified ADR Reporting 59
5.4 Targeted Spontaneous Reporting 60
5.5 Cohort Event Monitoring 61
5.6 EHR Mining 62
6 Segmentation of Europe Market by Delivery Mode 63
6.1 Market Overview by Delivery Mode 63
6.2 On-premise Delivery 65
6.3 On-demand Delivery 66
7 Segmentation of Europe Market by Indication 67
7.1 Market Overview by Indication 67
7.2 Oncology 69
7.3 Respiratory Disorders 70
7.4 Cardiology 71
7.5 Neurology 72
7.6 Immunology 73
7.7 Pain Management 74
7.8 Other Indications 75
8 Segmentation of Europe Market by End User 76
8.1 Market Overview by End User 76
8.2 Pharmaceutical and Biotechnology Companies 78
8.3 Contract Research Organizations (CROs) 79
8.4 Business Process Outsourcing Firms (BPOs) 80
8.5 Other End Users 81
9 European Market 2021-2031 by Country 82
9.1 Overview of European Market 82
9.2 Germany 85
9.3 U.K. 88
9.4 France 90
9.5 Spain 92
9.6 Italy 94
9.7 Netherlands 96
9.8 Rest of European Market 98
10 Competitive Landscape 100
10.1 Overview of Key Vendors 100
10.2 New Product Launch, Partnership, Investment, and M&A 103
10.3 Company Profiles 104
Ab Cube 104
Accenture PLC 106
ArisEurope LLC 107
Cognizant Technology Solutions Corporation 108
Ennov Solutions Inc. 109
Extedo GmbH 110
Honeywell International Inc. (Sparta Systems Inc.) 111
IQVIA Inc. 112
Max Application 113
Oracle Corporation 114
Sarjen Systems Pvt. Ltd. 115
United BioSource LLC 116
Veeva Systems Inc. 117
Wipro Limited 118
RELATED REPORTS 119
List of Tables:
Table 1. Snapshot of Europe Pharmacovigilance and Drug Safety Software Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. Main Product Trends and Market Opportunities in Europe Pharmacovigilance and Drug Safety Software Market 35
Table 5. Europe Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 43
Table 6. Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, $ mn 49
Table 7. Europe Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, $ mn 56
Table 8. Europe Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 63
Table 9. Europe Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, $ mn 67
Table 10. Europe Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 76
Table 11. Europe Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 84
Table 12. Germany Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 86
Table 13. Germany Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 86
Table 14. Germany Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 86
Table 15. U.K. Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 89
Table 16. U.K. Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 89
Table 17. U.K. Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 89
Table 18. France Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 91
Table 19. France Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 91
Table 20. France Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 91
Table 21. Spain Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 93
Table 22. Spain Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 93
Table 23. Spain Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 93
Table 24. Italy Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 95
Table 25. Italy Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 95
Table 26. Italy Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 95
Table 27. Netherlands Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 97
Table 28. Netherlands Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 97
Table 29. Netherlands Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 97
Table 30. Pharmacovigilance and Drug Safety Software Market in Rest of Europe by Country, 2021-2031, $ mn 99
Table 31. Ab Cube: Company Snapshot 104
Table 32. Ab Cube: Business Segmentation 105
Table 33. Ab Cube: Product Portfolio 105
List of Figures:
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. Europe Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 20
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of Europe Pharmacovigilance and Drug Safety Software Market 27
Figure 7. Percentage of Trial Participants by Country, 2015-2019 30
Figure 8. World Drug Discovery Market, 2019-2030, $ mn 31
Figure 9. Primary Restraints and Impact Factors of Europe Pharmacovigilance and Drug Safety Software Market 32
Figure 10. Investment Opportunity Analysis 36
Figure 11. Porter"s Fiver Forces Analysis of Europe Pharmacovigilance and Drug Safety Software Market 39
Figure 12. Breakdown of Europe Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, % of Revenue 44
Figure 13. Europe Addressable Market Cap in 2022-2031 by Functionality, Value ($ mn) and Share (%) 44
Figure 14. Europe Pharmacovigilance and Drug Safety Software Market by Functionality: Adverse Event Reporting Software, 2021-2031, $ mn 45
Figure 15. Europe Pharmacovigilance and Drug Safety Software Market by Functionality: Drug Safety Audits Software, 2021-2031, $ mn 46
Figure 16. Europe Pharmacovigilance and Drug Safety Software Market by Functionality: Issue Tracking Software, 2021-2031, $ mn 47
Figure 17. Europe Pharmacovigilance and Drug Safety Software Market by Functionality: Fully Integrated Software, 2021-2031, $ mn 48
Figure 18. Breakdown of Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, % of Sales Revenue 50
Figure 19. Europe Addressable Market Cap in 2022-2031 by Clinical Phase, Value ($ mn) and Share (%) 50
Figure 20. Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Pre-clinical, 2021-2031, $ mn 51
Figure 21. Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase I, 2021-2031, $ mn 52
Figure 22. Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase II, 2021-2031, $ mn 53
Figure 23. Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase III, 2021-2031, $ mn 54
Figure 24. Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase IV, 2021-2031, $ mn 55
Figure 25. Breakdown of Europe Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, % of Sales Revenue 57
Figure 26. Europe Addressable Market Cap in 2022-2031 by Method, Value ($ mn) and Share (%) 57
Figure 27. Europe Pharmacovigilance and Drug Safety Software Market by Method: Spontaneous Reporting, 2021-2031, $ mn 58
Figure 28. Europe Pharmacovigilance and Drug Safety Software Market by Method: Intensified ADR Reporting, 2021-2031, $ mn 59
Figure 29. Europe Pharmacovigilance and Drug Safety Software Market by Method: Targeted Spontaneous Reporting, 2021-2031, $ mn 60
Figure 30. Europe Pharmacovigilance and Drug Safety Software Market by Method: Cohort Event Monitoring, 2021-2031, $ mn 61
Figure 31. Europe Pharmacovigilance and Drug Safety Software Market by Method: EHR Mining, 2021-2031, $ mn 62
Figure 32. Breakdown of Europe Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, % of Revenue 64
Figure 33. Europe Addressable Market Cap in 2022-2031 by Delivery Mode, Value ($ mn) and Share (%) 64
Figure 34. Europe Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-premise Delivery, 2021-2031, $ mn 65
Figure 35. Europe Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-demand Delivery, 2021-2031, $ mn 66
Figure 36. Breakdown of Europe Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, % of Revenue 68
Figure 37. Europe Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 68
Figure 38. Europe Pharmacovigilance and Drug Safety Software Market by Indication: Oncology, 2021-2031, $ mn 69
Figure 39. Europe Pharmacovigilance and Drug Safety Software Market by Indication: Respiratory Disorders, 2021-2031, $ mn 70
Figure 40. Europe Pharmacovigilance and Drug Safety Software Market by Indication: Cardiology, 2021-2031, $ mn 71
Figure 41. Europe Pharmacovigilance and Drug Safety Software Market by Indication: Neurology, 2021-2031, $ mn 72
Figure 42. Europe Pharmacovigilance and Drug Safety Software Market by Indication: Immunology, 2021-2031, $ mn 73
Figure 43. Europe Pharmacovigilance and Drug Safety Software Market by Indication: Pain Management, 2021-2031, $ mn 74
Figure 44. Europe Pharmacovigilance and Drug Safety Software Market by Indication: Other Indications, 2021-2031, $ mn 75
Figure 45. Breakdown of Europe Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, % of Revenue 76
Figure 46. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 77
Figure 47. Europe Pharmacovigilance and Drug Safety Software Market by End User: Pharmaceutical and Biotechnology Companies, 2021-2031, $ mn 78
Figure 48. Europe Pharmacovigilance and Drug Safety Software Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 79
Figure 49. Europe Pharmacovigilance and Drug Safety Software Market by End User: Business Process Outsourcing Firms (BPOs), 2021-2031, $ mn 80
Figure 50. Europe Pharmacovigilance and Drug Safety Software Market by End User: Other End Users, 2021-2031, $ mn 81
Figure 51. Breakdown of European Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 83
Figure 52. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 84
Figure 53. Pharmacovigilance and Drug Safety Software Market in Germany, 2021-2031, $ mn 85
Figure 54. Pharmacovigilance and Drug Safety Software Market in U.K., 2021-2031, $ mn 88
Figure 55. Pharmacovigilance and Drug Safety Software Market in France, 2021-2031, $ mn 90
Figure 56. Pharmacovigilance and Drug Safety Software Market in Spain, 2021-2031, $ mn 92
Figure 57. Pharmacovigilance and Drug Safety Software Market in Italy, 2021-2031, $ mn 94
Figure 58. Pharmacovigilance and Drug Safety Software Market in Netherlands, 2021-2031, $ mn 96
Figure 59. Pharmacovigilance and Drug Safety Software Market in Rest of Europe, 2021-2031, $ mn 98
Figure 60. Growth Stage of Europe Pharmacovigilance and Drug Safety Software Industry over the Forecast Period 100
Selected Key Players:
Ab Cube
Accenture PLC
ArisGlobal LLC
Cognizant Technology Solutions Corporation
Ennov Solutions Inc.
Extedo GmbH
Honeywell International Inc. (Sparta Systems Inc.)
IQVIA Inc.
Max Application
Oracle Corporation
Sarjen Systems Pvt. Ltd.
United BioSource LLC
Veeva Systems Inc.
Wipro Limited
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)